A New Bioanalytical Method Development & Validation for Simultaneous Estimation of Esomeprazole and Naproxen in Human Plasma by Using RP-HPLC
Journal Title: Journal of Pharmaceutical Research International - Year 2014, Vol 4, Issue 19
Abstract
Aim: A new reverse phase high performance liquid chromatography (RP-HPLC) method for the quantitative determination of Esomeprazole and Naproxen in human plasma was developed and validated as per US-FDA guidelines. Methodology: The drug was spiked in the plasma and extracted with mobile phase by precipitation method. The extracted analyte was injected into Symmetry C18 (4.6 x 150mm, 5m, Make: XTerra) or equivalent, maintained at ambient temperature and effluent was monitored at 285nm. The mobile phase was composed of potassium dihydrogen phosphate and acetonitrile [HPLC Grade] in the ratio of 60:40. The pH of the potassium buffer was adjusted to 3.0 by using Ortho Phosphoric Acid. The flow rate was maintained at 1.0 mL/min. Results: The developed method shows high specificity for Esomeprazole and Naproxen. The calibration curve for Esomeprazole and Naproxen was linear from 1.0 to 6.0 ppm (r2= 0.999) and 25.0 to 150.0 ppm (r2= 0.999) respectively. The inter-day and intra-day precision was found to be within limits. The proposed method was adequate sensitivity, reproducibility, and specificity for the determination of esomeprazole and naproxen in plasma. The Lower limit of quantification (LLOQ) for the drug Esomeprazole and Naproxen were found to be 0.04µg/ml and 0.4µg/ml respectively. The average percent recovery for the drugs Esomeprazole and Naproxen were found to be 98.97-99.84 & 99.80-100.95 respectively and reproducibility was found to be satisfactory. Conclusion: The proposed method was accurate, and precise for the quantification of Esomeprazole and Naproxen in the plasma. The proposed can also be used for routine analysis in quality control. The method was validated for parameters like selectivity, sensitivity, precision, intermediate precision, accuracy, linearity, recovery & stability. This RP -HPLC method is suitable for determining the concentration of Esomeprazole and Naproxen in plasma and it can applied for routine analysis for determination of the Esomeprazole and Naproxen from dosage form during pharmacokinetic study.
Authors and Affiliations
S. Ashutosh Kumar, Manidipa Debnath, J. V. L. N. Seshagiri Rao, D. Gowri Sankar
Knowledge and Practice of Prevention of Mother-To-Child-Transmission of HIV among Traditional Birth Attendants Practicing in Akwa Ibom, Nigeria
Background: Transmission of HIV from mother to child is by far the most common route of HIV infection in children. It is estimated that without effective interventions, between 67,500 and 125,000 infants will be infected...
Cytotoxic Effect of Lingzhi Extracts on Gefitinib-resitant Lung Cancer Cells
Aims: The present study was carried out to investigate the cytotoxicity of extracts from Ganoderma and Amauroderma lingzhi species collected in Tay Nguyen, Vietnam. Methods: Mushroom samples were extracted by methanol an...
Solubilization of Poorly Water Soluble Drug Using Mixed Solvency Approach for Aqueous Injection
Aim: 1) To increase water solubility of indomethacin drug using mixed solvency approach. 2) To employ use of non toxic solubilizers for increasing solubility of a poorly water soluble drug. Study Design: Trial and error...
Comparison of Three Nutriceutical Food Supplements for the Treatment of Infertility
Aims: Approximately one out of every 8 couples is confronted with a problem of infertility. The diagnostic and therapeutic management, taking into account the WHO recommendations, may be complemented by nutriceutical foo...
Fed Bioequivalence Studies for Immediate Release Drug Products: Beneficial or Wastage?
Aims: The present study was undertaken to understand the need of fed bioequivalence studies for immediate release pharmaceutical products and thereby evaluating the relative appropriateness of guidelines given by the Eur...